Canberra man guilty of raping sex worker by way of stealthing jailed for more than two years
Warning: This story discusses sexual assault.
Aleksandar Ivanovski was charged with a single count of rape, after "stealthing" the woman in December 2021.
The court heard Ivanovski had been involved in a booking with another sex worker before engaging the victim for a half hour session.
He then obtained a 10 minute extension, for $100.
During the encounter Ivanovski had asked for unprotected sex, but the woman told him she didn't do "natural" services.
The woman said he had turned her to a position where she couldn't see what he was doing, and when she did turn around the condom was on the floor.
"What the f*** were you doing?" she said to him at the time.
"Did you just f****ing stealth me?"
Ivanovski denied it.
The woman reported the matter immediately to the manager who called police, and a statement was taken two days later.
But it was not until nearly a year later that Ivanovski became aware he was being investigated by police.
At his trial earlier this year the prosecution described Ivanovski's actions as driven by a sense of entitlement and called for full-time jail, saying the crime had been pre-meditated.
Today Acting Justice John Burns said Ivanovski had been clearly aware the woman was not consenting, but he found it was opportunistic, rather than a premeditated crime.
Acting Justice Burns told the court pre-sentence reports on Ivanovski recorded drug use including cocaine and methamphetamine, and noted his behaviour was emotionally driven.
He also noted Ivanovski was "reluctant to discuss the offending".
Acting Justice Burns said the reports indicated Ivanovski had been capable of understanding the situation.
"Your behaviour demonstrated you were well aware of the boundaries," Acting Justice Burns told Ivanovski.
"You have in fact demonstrated no remorse whatsoever."
Acting Justice Burns sentenced Ivanovski to two years and six months' jail, to be suspended after a year, ahead of a good behaviour order.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
41 minutes ago
- News.com.au
Biocurious: The cannabis stocks that stand out in a field of weeds
Cannabis suppliers are struggling to differentiate themselves in a commoditised market Regulators have lax telehealth prescribers in their sights Althea Group has sold its medical pot arm in favour of THC-infused beverages Having sprouted in a field of hope and hype eleven years ago, the ASX medicinal cannabis sector has wilted in the face of unrealistic expectations and misguided strategies. Demand isn't the problem: patients have embraced medical weed zealously since it was legalised a decade ago. Globally, most western countries have sanctioned both medical usage and many have condoned recreational indulgence (including most US states). Because there's only two approved cannabis treatments, local dispensing is largely carried out via an authorised prescriber scheme. In the six months to December 2024, these docs wrote 377,840 prescriptions. Of these, 230,091 were for products with a THC content of more than 98%. Patients aren't mucking around. What's not to like? The answer is rampant oversupply of the green stuff coupled with the rise of telehealth clinics, some of which are being criticised for alleged 'tick and flick' dispensing practices. Echoing Australian Medical Association concerns, Little Green Pharma (ASX:LGP) CEO Paul Long refers to 'poor actors' in the local market. 'Reports constantly refer to a handful of doctors, often junior doctors that are either being coerced, or paid exorbitant money to write a huge volume of THC scripts,' he says. 'I agree it is an issue and calling it out for the long-term growth of our industry is important." He adds hundreds of thousands have tried medical cannabis when nothing has worked, with great success. Reflecting the 'commoditised' market, Althea Group (ASX:AGH) in May sold its local medical cannabis business, Tasmanian Botanics Pty Ltd for a knock-down $1 million. 'The market has become irrational,' says Althea CEO Joshua Fegan. 'It's very saturated, with product from places like Canada, South Africa and Colombia'. He says most of the consumption is by way of dried flower, which implies folk might be smoking the devil's lettuce for jollies rather than using it medicinally. We'll delve further into Althea's new direction below. The dope on how to get it right While most suppliers have withered, a handful prosper via differentiated strategies and perhaps a bit of luck. They are producing meaningful revenues and – in some cases - profits. The Perth-based Little Green Pharma derives 80% of its revenue from the local market, but its greater fortunes align to the rapidly evolving European market. Germany is in the throes of partial legalisation. In France, the company supplies a pilot program that's a precursor to legalisation. Little Green's owns a production facility in Denmark – Europe's biggest – purchased from Canada's Canopy Growth for a knock-down $20 million three years ago. Two hours from the German border, the facility provides a streamlined route to the biggest Continental markets. 'It's very unlikely a site like this will be built again in the foreseeable future,' Little Green CEO Paul Long says. Meanwhile, the company's Busselton facility becomes a 'craft' producer of a small amount of slowly cured, hand trimmed, genetically superior stuff. Naturally, this attracts a better margin. In the year to March 2025 Little Green grew its revenue by 43%, to a record $36.8 million 'against a backdrop of significant regulatory change and intense competition'. European revenues doubled. Adjusted for non-cash items, Little Green managed underlying earnings of $2.9 million compared with a previous $1.6 million loss. From gummies to suppositories Bioxyne (ASX:BXN) has a modest $64 million market cap, but that's big enough to confer 'sector leader' status. Bioxyne's engine room is Breathe Life Sciences (BLS), acquired via scrip in 2023. BLS makes and distributes medical cannabis and other consumer health products, either under its own brands or third-party labels. (locally, Bioxyne is also the only licensed maker of MDMA and psilocybin for authorised prescribers and pyschedelic clinical trials). In 2019 the company launched in the UK and Japan via its well-known Dr Watson brand, covering everything from gummies, to vapes to suppositories. BLS too has entered the German market with a deal to supply a minimum 1.6 tonnes of cannabis flower and finished product to two clients. The company expects the agreement will reap a minimum of $5.6 million of revenue in the 2025-26 year. Ja, das ist gut! Bioxyne CEO Sam Watson expects German demand to rapidly overtake the $1 billion a year Australian market. On June 12 the company upgraded full-revenue expectations from $25 million to $28 million, a lofty step up from the previous year's $9.65 million. The Ebay of medicinal dope Formerly known as Cronos Australia, Vitura Health (ASX:VIT) doesn't produce any of its own material, but operates a marketplace that sells hundreds of flowers and oils from third party suppliers. Vitura also has expanded into prescription nicotine vapes. The company has built a network of physical and online prescribers, mainly via acquisition. Vitura owns the Canview marketplace, Doctors on Demand telehealth business, CDA Clinics (medical cannabis telehealth) and the clinic chain Candor Medical. In May, Vitura's 50% joint venture Flora acquired the digital platform Heyday Medical, 'one of Australia's most respected medicinal cannabis clinics'. Established in 2020, the chain claims to have serviced more than more than 5000 patients. Last November Flora acquired the Releaf Group, which operates telehealth and physical clinics. In a March quarter update, Vitura said full-year revenue was unlikely to meet the targeted 10% improvement. But the June quarter implies a yearly run rate of $138 million, up 11%. Management also expects a 20% improvement on last year's normalised underlying earnings of $8.4 million. Putting the pep into soft drinks Coming back to Althea, the company's new schtick is entering the North American market for THC-infused beverages. (THC is the psychoactive component of cannabis). Yep, these bevvies are legal in Canada and the US and are sold in bottle shops alongside alcohol. Althea's foray is by way of its subsidiary Peak. Althea's Fegan says when Peak started producing in 2021, only 4% of cannabis consumers had tried these drinks. Now, the number is more like one-quarter of them. He says the drinks have a similar effect to a similar sized serve of alcohol, but without the hangover. 'It ticks a lot of boxes as a good consumer product,' he says. Peak's competitive edge is its technique to produce the THC emulsion, without the 'planty' taste of dope. Peak's offerings include seltzers, sodas and mocktails – but it's not yet putting the 'pep' into Pepsi. Peak Canada has just launched its own brand Snap Back, a heady mix of THC and rosin (pine resin). By December Althea expects to have four or five US production sites, as close to distributors as possible. 'These big alcohol companies are looking closely at this space and our job is to develop drinks for those type of companies and produce them at scale," Fegan says. In the December half, Althea derived $8.2 million of revenue in Canada and the company expects this to grow during the summer months. Given the sale of its Australian business, Althea in May withdrew its full-year guidance of revenue between $26-33 million and underlying earnings of $800,000 to $1.1 million. Althea lost $2.6 million in the March quarter. But Fegan says the company should be cash flow positive without the drag of the divested Australian business.
News.com.au
an hour ago
- News.com.au
Australians warned against renting bank details to crime networks
Australians have been warned against some think is a 'harmless crime', by becoming 'money mules' and renting out their bank details to criminals. In its latest warning the Australian Federal Police said many Australians were knowingly or unknowingly becoming money mules for criminals who used their bank accounts to move illicit money into a personal account to make the funds appear legitimate. According to the Australian Banking Association, the major banks made moves to shut down almost 13,000 suspected accounts in the 2024 financial year, up from the 9000 accounts they had discovered in the previous year. The big increase was largely due to an increase in detection capabilities and greater intelligence sharing between the banks and law enforcement. These mules are paid anywhere between $200 to $500 plus a commission, which is usually 10 per cent on any money moved through the account. ABA chief executive Anna Bligh said mule accounts were a key part of a scammer's business model and banks were focused on identifying, investigating and shutting them down. 'Renting or selling your bank account may seem harmless, but you may be unwittingly helping a scammer to rip-off a family member or someone else you know,' she said. 'Don't let criminals cash in on your bank account. 'There's a good chance you're being recruited to hide the profits of criminal activity.' According to the AFP, criminals are targeting Australians through social media, messaging or gaming platforms, chat forums, online advertisements and even in face-to-face meetings. These individuals will then be recruited by money laundered in three main ways. •Employment scams – these are designed to exploit job seekers by offering what seems like quick and easy money for little work. Applicants are asked to have an Australian bank account to transfer funds and are promised a commission for their work. •Threat scams – scammers contact victims threatening criminal charges and arrest unless they transfer and receive funds. •Romance scams – scammers build a relationship online and then request the victim to transfer money to other accounts, typically overseas, using their personal bank account. From here the criminal networks are increasingly telling these money mules to move the funds into a cryptocurrency exchange or ATM and global money transfer apps to make it harder to detect. AFP Detective Superintendent Marie Andersson said it was illegal to rent, buy or sell bank account details. 'Your account may be housing money derived from scams, extortion, drug trafficking and terrorism,' Ms Andersson said 'If a criminal has access to your bank accounts and personal details, they may use this information to commit other crimes, potentially implicating you in their illegal activities.'
News.com.au
an hour ago
- News.com.au
Motorcyclist dead, traffic chaos after horror crash on M4 in Sydney
A man has died after being thrown from his motorcycle and then struck by a police car on Sydney's M4. The horror collision has sparked traffic chaos on the motorway on Wednesday morning. Police say the motorcycle collided with a white sedan on the M4 near Church St at Parramatta shortly before 2am, with the impact throwing the rider to the road. The man was then struck by a marked police vehicle. Police officers performed CPR before paramedics arrived on the scene, with the man rushed to Westmead Hospital. He could not be revived and is yet to be formally identified. The driver of sedan – a man whose age is yet to be identified – and a male senior constable were taken to the same hospital for mandatory testing.
